Your browser doesn't support javascript.
loading
TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner.
Jiang, Jie; Gao, Li; Lan, Yongting; Wang, Yang; Zhao, Peiqing.
Affiliation
  • Jiang J; Department of Clinical Laboratory, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, China.
  • Gao L; Department of Stomatology, Zibo Central Hospital, Shandong University, Zibo, China.
  • Lan Y; Center of Translational Medicine, Zibo Central Hospital, Shandong University, Zibo, China.
  • Wang Y; Department of Clinical Laboratory, Huantai County People's Hospital, Zibo, China.
  • Zhao P; Center of Translational Medicine, Zibo Central Hospital, Shandong University, Zibo, China.
Front Oncol ; 10: 593615, 2020.
Article in En | MEDLINE | ID: mdl-33520705
ABSTRACT
Previous studies have revealed that TIPE1 serves as a tumor suppressor gene in several tumor types. However, we demonstrated that TIPE1 can promote cervical cancer proliferation by suppressing p53 activity. Here, we showed that TIPE1 inhibits cervical cancer cell apoptosis both in vivo and in vitro. Mechanistically, we revealed that TIPE1 facilitates chemoresistance in a wild-type p53-dependent manner. The results indicated that TIPE1 is responsible for the transition from chemosensitivity to chemoresistance, and that it can serve as a promising target in cervical cancer chemotherapy.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2020 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2020 Document type: Article Affiliation country: China